SNP3 polymorphism in apo A-V gene is associated with small dense LDL particles in Type 2 diabetes
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To the Editor: The −1131 T>C (SNP3) polymorphism of apo A-V gene has been associated in some studies to an increase in triglycerides and in few cases to a decrease in HDL-cholesterol. Its frequency is 12% in Afro-Americans, 16% in Hispanics, 6 to 16% in Caucasians and 7% in a Spanish control cohort [1, 2, 3, 4] . The heterozygote subjects for rare SNP3 allele (C/T) are related to an increase in triglycerides in Hispanic and Caucasian men, although these data were not observed in another study where the increase in triglycerides was only statistically significant in homozygotes for the mutated allele [3] . Hypertriglyceridaemia is the main factor in determining the size of the LDL. There are many causes that influence the metabolism of triglycerides, some are primary, such as the apo E genotype, and others secondary. Type 2 diabetes mellitus is linked to different lipid disorders such as hypertriglyceridaemia, a decrease in HDL-cholesterol and an increase in small, dense LDL.
The aim of this study was to assess the frequency and the influence of SNP3 polymorphism on different lipid parameters, LPL activity and LDL subfractions in a diabetic population.
The study was approved by the Ethics Committee of our hospital. We selected 127 patients with Type 2 diabetes mellitus who had given their written consent.
Venous blood samples were taken after a 12-h fast. Cholesterol and triglyceride concentrations were measured by enzymatic techniques. LDL-cholesterol was calculated with direct measuring.
Using density gradient centrifugation according to the method described by Sanchez Quesada [5] , six LDL subfractions were isolated [1, 2, 3, 4, 5, 6] from lesser to greater density: LDL1 (1.020-1.026 g/ml), LDL2 (1.026-1.030 g/ml), LDL3 (1.030-1.036 g/ml), LDL4 (1.036-1.043 g/ml), LDL5 (1.043-1.051 g/ml), LDL6 (1.051-1.056 g/ml). Plasma lipase activity was measured according to a previous study [6] . SNP 3 genotyping was done according to methodology used previously [1] . We following the Hixon's method for Apo E restriction isotyping [7] .
To check the restriction technique, all samples with the mutated allele and part of those with the common allele were sequenced.
Statistical analysis was done with StatView (5.0.1 version) for Windows. Statistical significance was taken as a p value of less than 0.05. The only non-nominal variables were compared using Mann-Whitney U test. Fisher's exact test was applied to examine differences between rare and common allele groups.
We found 14 patients with the mutated allele in the SNP3 polymorphism, which gave us a mutated allele frequency of 11% in the group of 127 diabetic patients. Of the 127 patients, 16% had apo E genotype E 3 E 4 , 13% were E 3 E 2 and 71% were E 3 E 3 . Among the diabetic patients with E 3 E 3 genotype, there were no differences between the groups with the mutated allele and with the common one in SNP3 in the concentrations of total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol and apo B. The mean lipase lipoprotein activity was similar in the group of patients with the common allele and with the mutated one (230±103 pkat/ml vs 243±80 pkat/ml). The figures for the smaller, denser subfractions were higher in patients with the mutated allele in SNP3 polymorphism LDL5 (33.1±15.2 mg/dl vs 24.7±11.6 mg/dl, p<0.05) and LDL6 (18.9±11.0 mg/dl vs 13.2±5.8 mg/dl, p<0.05), whereas no differences were noted among the rest of the LDL subfractions LDL1, LDL2, LDL3 and LDL4.
